These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 12766786

  • 1. Botulinum toxin as a preventive treatment for migraine and chronic tension headache.
    Cattin T.
    N Z Med J; 2003 May 16; 116(1174):U440. PubMed ID: 12766786
    [No Abstract] [Full Text] [Related]

  • 2. Botulinum toxin type A for the treatment of headache: why we say yes.
    Ashkenazi A, Silberstein S.
    Arch Neurol; 2008 Jan 16; 65(1):146-9. PubMed ID: 18195155
    [No Abstract] [Full Text] [Related]

  • 3. BOTOX for headache treatment.
    Rothrock JF.
    Headache; 2007 Feb 16; 47(2):345-6. PubMed ID: 17300388
    [No Abstract] [Full Text] [Related]

  • 4. Duration of migraine is a predictor for response to botulinum toxin type A.
    Eross EJ, Gladstone JP, Lewis S, Rogers R, Dodick DW.
    Headache; 2005 Apr 16; 45(4):308-14. PubMed ID: 15836566
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Botulinum toxin type A for the treatment of headache: con.
    Welch KM.
    Headache; 2004 Sep 16; 44(8):831-3. PubMed ID: 15330835
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Botulinum toxin in migraine prophylaxis.
    Göbel H.
    J Neurol; 2004 Feb 16; 251 Suppl 1():I8-11. PubMed ID: 14991336
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Predicting migraine responsiveness to botulinum toxin type A injections.
    Kim CC, Bogart MM, Wee SA, Burstein R, Arndt KA, Dover JS.
    Arch Dermatol; 2010 Feb 16; 146(2):159-63. PubMed ID: 20157026
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Botulinum toxin A. An alternative treatment for migraine.
    Moses LL.
    Adv Nurse Pract; 2009 Dec 16; 17(12):40-1. PubMed ID: 20014704
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.